ONTOLOGY REPORT - ANNOTATIONS
| Term: | hexachlorobenzene |
|
| Accession: | CHEBI:5692
|
browse the term
|
| Definition: | A chlorobenzene that has formula C6Cl6. |
| Synonyms: | related_synonym: | 1,2,3,4,5,6-hexachlorobenzene; C6Cl6; Clc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl; HCB; Hexachlorbenzol; InChI=1S/C6Cl6/c7-1-2(8)4(10)6(12)5(11)3(1)9; InChIKey=CKAPSXZOOQJIBF-UHFFFAOYSA-N; perchlorobenzene; phenyl perchloryl |
| | xref_casrn: | 118-74-1 |
| | xref: | Beilstein:1912585 "Beilstein Registry Number"; ChEMBL:481519 "ChEMBL COMPOUND"; ChemIDplus:118-74-1 "CAS Registry Number"; Gmelin:27278 "Gmelin Registry Number"; KEGG COMPOUND:118-74-1 "CAS Registry Number"; KEGG COMPOUND:C11042 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D006581 |
| | xref: | NIST Chemistry WebBook:118-74-1 "CAS Registry Number" |
|
|
hexachlorobenzene
|
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
affects binding |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
affects binding |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
increases localization |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Aif1 |
allograft inflammatory factor 1 |
|
affects expression |
ISO |
17 |
35,307,937 |
35,312,946 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt2 |
thymoma viral proto-oncogene 2 |
|
multiple interactions |
ISO |
7 |
28,376,579 |
28,424,472 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate, delta-, dehydratase |
|
affects expression |
ISO |
4 |
62,170,204 |
62,181,097 |
RGD:6480464 |
CTD |
| G |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
|
increases expression |
ISO |
X |
146,981,960 |
147,005,165 |
RGD:6480464 |
CTD |
| G |
Alox15 |
arachidonate 15-lipoxygenase |
|
increases expression |
ISO |
11 |
70,157,649 |
70,165,533 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
affects expression |
ISO |
5 |
150,076,634 |
150,099,623 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
increases expression |
ISO |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Art2b |
ADP-ribosyltransferase 2b |
|
decreases expression |
ISO |
7 |
108,727,374 |
108,729,675 |
RGD:6480464 |
CTD |
| G |
Art2b |
ADP-ribosyltransferase 2b |
|
decreases expression |
ISO |
7 |
108,727,374 |
108,729,675 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
decreases expression |
ISO |
6 |
120,843,137 |
120,866,838 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, beta polypeptide |
|
increases expression |
ISO |
4 |
136,436,060 |
136,442,092 |
RGD:6480464 |
CTD |
| G |
C4bp |
complement component 4 binding protein |
|
increases expression |
ISO |
1 |
132,532,498 |
132,558,195 |
RGD:6480464 |
CTD |
| G |
C920025E04Rik |
RIKEN cDNA C920025E04 gene |
|
increases expression |
ISO |
17 |
36,246,172 |
36,248,615 |
RGD:6480464 |
CTD |
| G |
Capg |
capping protein (actin filament), gelsolin-like |
|
increases expression |
ISO |
6 |
72,494,433 |
72,512,974 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
affects expression |
ISO |
9 |
5,298,517 |
5,307,281 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases activity |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Ccbp2 |
chemokine binding protein 2 |
|
increases expression |
ISO |
9 |
121,807,582 |
121,820,182 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
ISO |
1 |
83,113,341 |
83,115,742 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 antigen |
|
increases expression |
ISO |
18 |
36,884,721 |
36,886,308 |
RGD:6480464 |
CTD |
| G |
Cd24a |
CD24a antigen |
|
affects expression |
ISO |
10 |
43,298,975 |
43,304,071 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 antigen |
|
increases expression |
ISO |
5 |
17,287,508 |
17,394,777 |
RGD:6480464 |
CTD |
| G |
Cd37 |
CD37 antigen |
|
decreases expression |
ISO |
7 |
52,489,002 |
52,494,209 |
RGD:6480464 |
CTD |
| G |
Cd3d |
CD3 antigen, delta polypeptide |
|
decreases expression |
ISO |
9 |
44,789,869 |
44,795,135 |
RGD:6480464 |
CTD |
| G |
Cd48 |
CD48 antigen |
|
affects expression |
ISO |
1 |
173,612,186 |
173,635,388 |
RGD:6480464 |
CTD |
| G |
Cd5 |
CD5 antigen |
|
affects expression |
ISO |
19 |
10,792,633 |
10,813,464 |
RGD:6480464 |
CTD |
| G |
Cd52 |
CD52 antigen |
|
increases expression |
ISO |
4 |
133,649,453 |
133,650,988 |
RGD:6480464 |
CTD |
| G |
Cd59b |
CD59b antigen |
|
increases expression |
ISO |
2 |
103,911,167 |
103,925,114 |
RGD:6480464 |
CTD |
| G |
Cd63 |
CD63 antigen |
|
increases expression |
ISO |
10 |
128,345,975 |
128,349,878 |
RGD:6480464 |
CTD |
| G |
Cd74 |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
|
decreases expression |
ISO |
18 |
60,963,503 |
60,972,306 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 antigen |
|
increases expression |
ISO |
6 |
125,410,284 |
125,444,773 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cish |
cytokine inducible SH2-containing protein |
|
increases expression |
ISO |
9 |
107,199,020 |
107,204,292 |
RGD:6480464 |
CTD |
| G |
Clec4f |
C-type lectin domain family 4, member f |
|
increases expression |
ISO |
6 |
83,594,536 |
83,606,110 |
RGD:6480464 |
CTD |
| G |
Cma1 |
chymase 1, mast cell |
|
increases expression |
ISO |
14 |
56,560,288 |
56,563,498 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin |
|
increases expression |
ISO |
3 |
19,857,054 |
19,907,609 |
RGD:6480464 |
CTD |
| G |
Cpa3 |
carboxypeptidase A3, mast cell |
|
increases expression |
ISO |
3 |
20,115,515 |
20,142,080 |
RGD:6480464 |
CTD |
| G |
Csf2rb |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
|
increases expression |
ISO |
15 |
78,156,420 |
78,181,431 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
increases expression |
ISO |
5 |
91,320,271 |
91,322,147 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
affects expression |
ISO |
5 |
92,775,667 |
92,777,880 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
ISO |
5 |
91,188,325 |
91,190,651 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
1 |
130,484,776 |
130,488,876 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
17 |
80,106,293 |
80,114,381 |
RGD:6480464 |
CTD |
| G |
Cyp2a4 |
cytochrome P450, family 2, subfamily a, polypeptide 4 |
|
increases expression |
ISO |
7 |
27,092,211 |
27,100,107 |
RGD:6480464 |
CTD |
| G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
|
increases expression |
ISO |
7 |
26,682,683 |
26,711,643 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
affects expression |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
increases expression |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp4a12b |
cytochrome P450, family 4, subfamily a, polypeptide 12B |
|
increases expression |
ISO |
4 |
115,084,229 |
115,111,639 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
3 |
17,971,950 |
18,143,338 |
RGD:6480464 |
CTD |
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
decreases activity |
ISO |
4 |
106,964,070 |
106,979,748 |
RGD:6480464 |
CTD |
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
increases activity |
ISO |
4 |
106,964,070 |
106,979,748 |
RGD:6480464 |
CTD |
| G |
EG628438 |
predicted gene, EG628438 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Emb |
embigin |
|
increases expression |
ISO |
13 |
118,009,380 |
118,063,222 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal |
|
increases expression |
ISO |
1 |
182,919,687 |
182,947,626 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
decreases expression |
ISO |
14 |
66,703,214 |
66,743,337 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
increases phosphorylation |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
increases phosphorylation |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
increases expression |
ISO |
19 |
34,365,149 |
34,402,260 |
RGD:6480464 |
CTD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
1 |
163,710,820 |
163,718,626 |
RGD:6480464 |
CTD |
| G |
Fcer1a |
Fc receptor, IgE, high affinity I, alpha polypeptide |
|
increases expression |
ISO |
1 |
175,151,402 |
175,157,360 |
RGD:6480464 |
CTD |
| G |
Fcer2a |
Fc receptor, IgE, low affinity II, alpha polypeptide |
|
decreases expression |
ISO |
8 |
3,681,737 |
3,694,174 |
RGD:6480464 |
CTD |
| G |
Fcgr3 |
Fc receptor, IgG, low affinity III |
|
increases expression |
ISO |
1 |
172,981,300 |
172,989,534 |
RGD:6480464 |
CTD |
| G |
Fcgrt |
Fc receptor, IgG, alpha chain transporter |
|
increases expression |
ISO |
7 |
52,348,363 |
52,359,192 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
1 |
71,632,097 |
71,699,745 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone beta |
|
multiple interactions |
ISO |
2 |
106,896,297 |
106,899,808 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone beta |
|
decreases expression |
ISO |
2 |
106,896,297 |
106,899,808 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
|
increases expression |
ISO |
3 |
121,948,510 |
121,969,566 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
multiple interactions |
ISO |
X |
98,572,676 |
98,580,964 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
decreases expression |
ISO |
X |
98,572,676 |
98,580,964 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
multiple interactions |
ISO |
X |
98,572,676 |
98,580,964 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
decreases expression |
ISO |
X |
98,572,676 |
98,580,964 |
RGD:6480464 |
CTD |
| G |
Gjb2 |
gap junction protein, beta 2 |
|
decreases expression |
ISO |
14 |
57,717,439 |
57,723,539 |
RGD:6480464 |
CTD |
| G |
Glg1 |
golgi apparatus protein 1 |
|
affects expression |
ISO |
8 |
113,681,448 |
113,783,102 |
RGD:6480464 |
CTD |
| G |
Glycam1 |
glycosylation dependent cell adhesion molecule 1 |
|
increases expression |
ISO |
15 |
103,393,193 |
103,395,509 |
RGD:6480464 |
CTD |
| G |
Gm5077 |
predicted gene 5077 |
|
increases expression |
ISO |
6 |
124,574,643 |
124,586,103 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
affects expression |
ISO |
11 |
54,716,355 |
54,723,889 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase, alpha 2 (Yc2) |
|
affects expression |
ISO |
9 |
78,178,827 |
78,194,952 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase, alpha 3 |
|
increases expression |
ISO |
1 |
21,230,670 |
21,255,640 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase, mu 1 |
|
decreases expression |
ISO |
3 |
107,815,168 |
107,820,891 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase, mu 2 |
|
increases expression |
ISO |
3 |
107,784,620 |
107,789,354 |
RGD:6480464 |
CTD |
| G |
H2-Ab1 |
histocompatibility 2, class II antigen A, beta 1 |
|
affects expression |
ISO |
17 |
34,400,172 |
34,406,363 |
RGD:6480464 |
CTD |
| G |
H2-Ab1 |
histocompatibility 2, class II antigen A, beta 1 |
|
increases expression |
ISO |
17 |
34,400,172 |
34,406,363 |
RGD:6480464 |
CTD |
| G |
H2-DMa |
histocompatibility 2, class II, locus DMa |
|
decreases expression |
ISO |
17 |
34,272,616 |
34,275,480 |
RGD:6480464 |
CTD |
| G |
H2-DMb1 |
histocompatibility 2, class II, locus Mb1 |
|
decreases expression |
ISO |
17 |
34,290,136 |
34,297,174 |
RGD:6480464 |
CTD |
| G |
H2-Ea-ps |
histocompatibility 2, class II antigen E alpha, pseudogene |
|
decreases expression |
ISO |
17 |
34,478,902 |
34,484,492 |
RGD:6480464 |
CTD |
| G |
H2-Eb1 |
histocompatibility 2, class II antigen E beta |
|
affects expression |
ISO |
17 |
34,442,812 |
34,453,619 |
RGD:6480464 |
CTD |
| G |
H2-T23 |
histocompatibility 2, T region locus 23 |
|
increases expression |
ISO |
17 |
36,166,922 |
36,169,646 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
increases expression |
ISO |
2 |
126,419,404 |
126,444,401 |
RGD:6480464 |
CTD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
increases expression |
ISO |
9 |
44,144,431 |
44,152,311 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hp |
haptoglobin |
|
increases expression |
ISO |
8 |
112,099,028 |
112,103,072 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
decreases expression |
ISO |
8 |
120,225,846 |
120,282,929 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
ISO |
1 |
55,144,992 |
55,148,161 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
9 |
20,820,404 |
20,833,241 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
affects expression |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
increases expression |
ISO |
7 |
75,097,143 |
75,378,553 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
multiple interactions |
ISO |
7 |
75,097,143 |
75,378,553 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
increases expression |
ISO |
7 |
75,097,143 |
75,378,553 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
multiple interactions |
ISO |
7 |
75,097,143 |
75,378,553 |
RGD:6480464 |
CTD |
| G |
Igsf6 |
immunoglobulin superfamily, member 6 |
|
affects expression |
ISO |
7 |
128,207,581 |
128,218,044 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
affects expression |
ISO |
1 |
132,916,422 |
132,921,547 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
ISO |
1 |
132,916,422 |
132,921,547 |
RGD:6480464 |
CTD |
| G |
Il15 |
interleukin 15 |
|
decreases expression |
ISO |
8 |
84,855,523 |
84,926,444 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
increases expression |
ISO |
9 |
50,373,473 |
50,389,942 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
affects expression |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
ISO |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha chain |
|
increases expression |
ISO |
2 |
11,564,419 |
11,614,821 |
RGD:6480464 |
CTD |
| G |
Il2rb |
interleukin 2 receptor, beta chain |
|
affects expression |
ISO |
15 |
78,310,978 |
78,325,496 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
affects expression |
ISO |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
decreases expression |
ISO |
11 |
53,534,296 |
53,538,605 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
increases expression |
ISO |
13 |
113,254,278 |
113,297,068 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
increases expression |
ISO |
8 |
3,150,922 |
3,279,617 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
increases expression |
ISO |
8 |
3,150,922 |
3,279,617 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
decreases expression |
ISO |
11 |
53,583,516 |
53,591,876 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
increases phosphorylation |
ISO |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
multiple interactions |
ISO |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
increases expression |
ISO |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
multiple interactions |
ISO |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
increases phosphorylation |
ISO |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases expression |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases expression |
ISO |
2 |
32,240,157 |
32,243,259 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lman1 |
lectin, mannose-binding, 1 |
|
increases expression |
ISO |
18 |
66,140,393 |
66,162,289 |
RGD:6480464 |
CTD |
| G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
|
affects expression |
ISO |
13 |
112,536,641 |
112,599,191 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
affects localization |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen-activated protein kinase 14 |
|
affects expression |
ISO |
17 |
28,828,287 |
28,885,350 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
affects localization |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mcpt4 |
mast cell protease 4 |
|
increases expression |
ISO |
14 |
56,678,581 |
56,681,147 |
RGD:6480464 |
CTD |
| G |
Mcpt8 |
mast cell protease 8 |
|
increases expression |
ISO |
14 |
56,701,000 |
56,704,034 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mpst |
mercaptopyruvate sulfurtransferase |
|
increases expression |
ISO |
15 |
78,237,142 |
78,244,445 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases expression |
ISO |
4 |
147,822,691 |
147,931,794 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
increases expression |
ISO |
4 |
63,005,600 |
63,009,196 |
RGD:6480464 |
CTD |
| G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
|
increases expression |
ISO |
7 |
19,470,039 |
19,475,787 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
decreases expression |
ISO |
5 |
136,165,084 |
136,211,195 |
RGD:6480464 |
CTD |
| G |
Ppap2c |
phosphatidic acid phosphatase type 2C |
|
increases expression |
ISO |
10 |
78,989,174 |
78,996,532 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
increases expression |
ISO |
8 |
87,493,547 |
87,498,212 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Rgcc |
regulator of cell cycle |
|
affects expression |
ISO |
14 |
79,688,557 |
79,701,442 |
RGD:6480464 |
CTD |
| G |
Rxrb |
retinoid X receptor beta |
|
increases activity |
ISO |
17 |
34,168,797 |
34,175,344 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 (calgranulin A) |
|
increases expression |
ISO |
3 |
90,472,993 |
90,473,956 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 (calgranulin B) |
|
increases expression |
ISO |
3 |
90,496,555 |
90,499,613 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
affects expression |
ISO |
10 |
94,874,124 |
94,879,491 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
increases expression |
ISO |
11 |
117,827,393 |
117,830,680 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
affects expression |
ISO |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
affects expression |
ISO |
5 |
52,755,043 |
52,760,977 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
multiple interactions |
ISO |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
increases phosphorylation |
ISO |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
multiple interactions |
ISO |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
multiple interactions |
ISO |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
multiple interactions |
ISO |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
multiple interactions |
ISO |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
increases expression |
ISO |
1 |
52,176,282 |
52,218,707 |
RGD:6480464 |
CTD |
| G |
Stat5b |
signal transducer and activator of transcription 5B |
|
multiple interactions |
ISO |
11 |
100,642,045 |
100,711,899 |
RGD:6480464 |
CTD |
| G |
Stat5b |
signal transducer and activator of transcription 5B |
|
multiple interactions |
ISO |
11 |
100,642,045 |
100,711,899 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family 1A, phenol-preferring, member 1 |
|
increases expression |
ISO |
7 |
133,816,384 |
133,819,871 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, member 1 |
|
increases expression |
ISO |
5 |
88,004,993 |
88,020,636 |
RGD:6480464 |
CTD |
| G |
Tcrb |
T cell receptor beta chain |
|
decreases expression |
ISO |
6 |
40,841,295 |
41,508,370 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
affects expression |
ISO |
16 |
32,608,982 |
32,632,880 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
decreases expression |
ISO |
12 |
87,397,693 |
87,419,991 |
RGD:6480464 |
CTD |
| G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
|
increases expression |
ISO |
X |
20,447,292 |
20,451,863 |
RGD:6480464 |
CTD |
| G |
Timp2 |
tissue inhibitor of metalloproteinase 2 |
|
increases expression |
ISO |
11 |
118,162,375 |
118,216,725 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
increases expression |
ISO |
6 |
125,299,741 |
125,312,501 |
RGD:6480464 |
CTD |
| G |
Trf |
transferrin |
|
increases expression |
ISO |
9 |
103,111,206 |
103,132,616 |
RGD:6480464 |
CTD |
| G |
Tsc22d1 |
TSC22 domain family, member 1 |
|
decreases expression |
ISO |
14 |
76,815,628 |
76,907,573 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
affects binding |
ISO |
18 |
20,823,751 |
20,832,827 |
RGD:6480464 |
CTD |
| G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
|
increases expression |
ISO |
5 |
87,345,664 |
87,355,528 |
RGD:6480464 |
CTD |
| G |
Ugt8a |
UDP galactosyltransferase 8A |
|
increases expression |
ISO |
3 |
125,568,261 |
125,641,468 |
RGD:6480464 |
CTD |
| G |
Urod |
uroporphyrinogen decarboxylase |
|
affects expression |
ISO |
4 |
116,662,822 |
116,666,980 |
RGD:6480464 |
CTD |
| G |
Urod |
uroporphyrinogen decarboxylase |
|
multiple interactions |
EXP |
4 |
116,662,822 |
116,666,980 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
3 |
115,812,938 |
115,832,606 |
RGD:6480464 |
CTD |
Term paths to the root
|